Latest NZX Announcements

The Share Purchase Plan (SPP) offer document and forms will be mailed to eligible shareholders today.

Eligible shareholders and Wholesale investors will receive their personalised application forms to apply for up to a maximum of NZ$50,000 of new shares, at $0.05…

TruScreen is pleased to advise that it has received approval from the MOH of the Vietnam Government for the commercial roll-out of the TruScreen cervical…

Real time cervical cancer screening technology company TruScreen (NZX: TRU or ”Company”) is pleased to provide it's April market update on its various commercial operations.

TruScreen Limited (NZX:TRU) is pleased to announce the appointment of Ms Victoria Potarina as Chief Executive Officer, commencing 2 March 2020.

The Company has appointed RSM Hayes Audit Auckland as auditors of the Company with immediate effect.

China manufacturing approvals expected to provide TruScreen greater market access. Local manufacturing contracts in China under negotiation with expected reduction in component costs. Novel Coronavirus…

TruScreen’s real-time cervical cancer screening device has demonstrated improved sensitivity and specificity targeting pre-cancerous and cancerous cervical cells compared to a Pap test in a…

TruScreen Unaudited Preliminary Results for the Half Year Ending 30 September 2019

TruScreen is pleased to provide a copy of its November 2019 Stakeholder newsletter.